Literature DB >> 10807635

Economic note: cost of illness studies.

S Byford1, D J Torgerson, J Raftery.   

Abstract

Mesh：

Year:  2000        PMID： 10807635      PMCID： PMC1127320          DOI： 10.1136/bmj.320.7245.1335

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Cost of illness studies in health care: a comparison of two cases.

Authors:  A Ament; S Evers
Journal:  Health Policy       Date:  1993-11       Impact factor: 2.980

2.  Cost of illness studies: no aid to decision making: Reply to Shiell et al. (Health Policy, 8 (1987) 317-323).

Authors:  C Behrens; K Henke
Journal:  Health Policy       Date:  1988-10       Impact factor: 2.980

3.  Cost-effectiveness analysis.

Authors:  R Robinson
Journal:  BMJ       Date:  1993-09-25

4.  Cost-of-illness studies: fact or fiction?

Authors:  D P Rice
Journal:  Lancet       Date:  1994-12-03       Impact factor: 79.321
  4 in total
  79 in total

Review 1.  Economic modelling before clinical trials.

Authors:  David J Torgerson; Sarah Byford
Journal:  BMJ       Date:  2002-07-13

Review 2.  Cost-of-Illness Studies: An Updated Review of Current Methods.

Authors:  Eberechukwu Onukwugha; Jacquelyn McRae; Alex Kravetz; Stefan Varga; Rahul Khairnar; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

3.  Healthcare and social services resource use and costs of self-harm patients.

Authors:  Julia M A Sinclair; Alastair Gray; Oliver Rivero-Arias; Kate E A Saunders; Keith Hawton
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-02-21       Impact factor: 4.328

4.  [Conceptual and methodological basics of cost assessments in rheumatology].

Authors:  J Ruof; J L Hülsemann; T Mittendorf; J-M von der Schulenburg; H Zeidler; S Merkesdal
Journal:  Z Rheumatol       Date:  2004-10       Impact factor: 1.372

Review 5.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.

Authors:  Mark Oremus; S Carolina Aguilar
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

7.  Estimating the cost related to surveillance of colorectal cancer in a French population.

Authors:  Catherine Lejeune; Christine Binquet; Franck Bonnetain; Amel Mahboubi; Michal Abrahamowicz; Thierry Moreau; Maria Raikou; Laurent Bedenne; Catherine Quantin; Claire Bonithon-Kopp
Journal:  Eur J Health Econ       Date:  2009-03-04

8.  Total economic cost and burden of dengue in Nicaragua: 1996-2010.

Authors:  Zachary S Wettstein; Michael Fleming; Aileen Y Chang; David J Copenhaver; Angela R Wateska; Sarah M Bartsch; Bruce Y Lee; Rajan P Kulkarni
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

9.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.